Key Highlights: Consolidated Financial Performance:Revenue growth driven by Health Care Benefits segment, offset by declines in Health Services and Pharmacy & Consumer Wellness. Operating income significantly impacted by opioid litigation charge and loss on assets held for sale. Net income down substantially compared to prior year, primarily due to the aforementioned charges and lower operating income. Segment Performance:Health Care Benefits: Strong revenue growth driven by increased premiums, partially offset by higher health care costs. Health Services: Revenue decline due to loss of a large client, partially offset by growth in specialty and mail order pharmacy. Pharmacy & Consumer Wellness: Revenue growth driven by increased prescription volume and same-store sales, offset by lower front store sales. Financial Position and Liquidity:Strong cash position and access to credit facilities. Active share repurchase program continues. Debt ratings under review for downgrade. Litigation and Regulatory Matters:Ongoing opioid litigation and PBM investigations present potential risks. Class action lawsuits filed regarding Health Care Benefits segment profitability. Forward-Looking Statements:Management highlights growth opportunities in integrated care delivery and health services. Future performance subject to various risks and uncertainties.